Erratum to Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients
2018-03-19 07:23:39AminaMaimaitiailiDiWuZhenyuLiuHaimengLiuXiamusiyeMuyiduliZhiminFan
Cancer Biology & Medicine 2018年4期
Amina Maimaitiaili, Di Wu, Zhenyu Liu, Haimeng Liu, Xiamusiye Muyiduli, Zhimin Fan
1Department of Breast Surgery, The First Hospital of Jilin University, Changchun 130021, China; 2Department of Epidemiology & Health Statistics, School of Public Health, School of Medicine, Zhejiang University, Hangzhou 310058, China
In the published article1, some errors appeared in the use of abbreviations. Sentinel lymph node should be referred as SLN instead of NSLN, non-sentinel lymph node should be referred as non-SLN instead of non-NSLN. Only in the Figure 1 and Table 1, NSLN means non-SLN. We apologize for the errors and for any confusion it may have caused.
Cancer Biology & Medicine2018年4期
- Cancer Biology & Medicine的其它文章
- 2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer
- Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor
- Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective singlecenter randomized study
- Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment
- PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs
- Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients